Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M17,380Revenue $M7,143Net Margin (%)-1.7Z-Score0.9
Enterprise Value $M21,438EPS $-0.1Operating Margin %1.7F-Score7
P/E(ttm))46.8Cash Flow Per Share $1.5Pre-tax Margin (%)-3.1Higher ROA y-yY
Price/Book2.610-y EBITDA Growth Rate %0Quick Ratio1.2Cash flow > EarningsY
Price/Sales2.45-y EBITDA Growth Rate %0Current Ratio1.7Lower Leverage y-yN
Price/Cash Flow3.8y-y EBITDA Growth Rate %0ROA % (ttm)-0.7Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-1.9Less Shares Outstanding y-yY
Payout Ratio %0Shares Outstanding M1,323ROI % (ttm)-9.4Gross Margin Increase y-yY

Gurus Latest Trades with BSX

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BSXVanguard Health Care Fund 2014-06-30 Add0.2%$12.58 - $13.77
($13.01)
$ 13.141%Add 16.19%42,743,200
BSXRay Dalio 2014-03-31 Reduce-0.01%$11.91 - $13.98
($13.08)
$ 13.140%Reduce -70.15%36,884
BSXMichael Price 2013-12-31 Add0.47%$11.18 - $12.38
($11.81)
$ 13.1411%Add 17.65%2,000,000
BSXRay Dalio 2013-12-31 Buy 0.01%$11.18 - $12.38
($11.81)
$ 13.1411%New holding, 123584 sh.123,584
BSXLeon Cooperman 2013-12-31 Reduce-0.88%$11.18 - $12.38
($11.81)
$ 13.1411%Reduce -36.64%8,533,099
BSXDodge & Cox 2013-12-31 Reduce-0.18%$11.18 - $12.38
($11.81)
$ 13.1411%Reduce -22.34%45,938,468
BSXJoel Greenblatt 2013-12-31 Sold Out -0.01%$11.18 - $12.38
($11.81)
$ 13.1411%Sold Out0
BSXLeon Cooperman 2013-09-30 Reduce-0.42%$9.15 - $11.99
($10.83)
$ 13.1421%Reduce -18.19%13,467,416
BSXDodge & Cox 2013-09-30 Reduce-0.25%$9.15 - $11.99
($10.83)
$ 13.1421%Reduce -27.68%59,157,107
BSXVanguard Health Care Fund 2013-09-30 Reduce-0.24%$9.15 - $11.99
($10.83)
$ 13.1421%Reduce -15.74%38,240,700
BSXCharles Brandes 2013-09-30 Sold Out -0.07%$9.15 - $11.99
($10.83)
$ 13.1421%Sold Out0
BSXJoel Greenblatt 2013-09-30 Reduce-0.02%$9.15 - $11.99
($10.83)
$ 13.1421%Reduce -69.22%18,744
BSXCharles Brandes 2013-06-30 Reduce-1.54%$7.09 - $9.64
($8.48)
$ 13.1455%Reduce -96.31%624,088
BSXDodge & Cox 2013-06-30 Reduce-0.14%$7.09 - $9.64
($8.48)
$ 13.1455%Reduce -14.79%81,801,130
BSXJoel Greenblatt 2013-06-30 Reduce-0.03%$7.09 - $9.64
($8.48)
$ 13.1455%Reduce -51.28%60,894
BSXLeon Cooperman 2013-03-31 Add0.24%$5.73 - $7.81
($7.12)
$ 13.1485%Add 13.43%16,473,300
BSXJoel Greenblatt 2013-03-31 Reduce-0.01%$5.73 - $7.81
($7.12)
$ 13.1485%Reduce -20.11%124,980
BSXRay Dalio 2013-03-31 Sold Out -0.0025%$5.73 - $7.81
($7.12)
$ 13.1485%Sold Out0
BSXMichael Price 2012-12-31 Add0.16%$5.07 - $5.82
($5.49)
$ 13.14139%Add 13.33%1,700,000
BSXMario Gabelli 2012-12-31 Add0.02%$5.07 - $5.82
($5.49)
$ 13.14139%Add 20.63%2,418,305
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BSX is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
BSX Vanguard Health Care Fund 2014-06-3042,743,2003.231.4+16.19%
BSX PRIMECAP Management 2014-03-3149,351,8193.730.76+1.96%
BSX Michael Price 2014-03-312,000,0000.153.3
BSX Leon Cooperman 2014-03-318,533,0990.651.5
BSX Dodge & Cox 2014-03-3145,224,1683.420.63-1.55%
BSX Mario Gabelli 2014-03-312,099,0050.160.15-4.65%
BSX Ray Dalio 2014-03-3136,88400-70.15%
Premium Most recent portfolio changes are included for Premium Members only!


BSX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Pierce David ASVP and President, Endoscopy 2014-07-30Sell157$12.971.31view
Phalen Michael P.EVP & President, MedSurg 2014-07-15Sell67,500$13.040.77view
MARIO ERNESTDirector 2014-07-01Sell10,000$12.951.47view
Phalen Michael P.EVP & President, MedSurg 2014-06-16Sell13,500$13.020.92view
MARIO ERNESTDirector 2014-06-02Sell10,000$12.882.02view
Phalen Michael P.EVP & President, MedSurg 2014-05-15Sell13,500$12.762.98view
MARIO ERNESTDirector 2014-05-01Sell10,000$12.584.45view
Phalen Michael P.EVP & President, MedSurg 2014-04-15Sell13,500$13.25-0.83view
MARIO ERNESTDirector 2014-04-01Sell10,000$13.55-3.03view
Phalen Michael P.EVP & President, MedSurg 2014-03-17Sell13,500$13.050.69view

Press Releases about BSX :

    Quarterly/Annual Reports about BSX:

    News about BSX:

    Articles On GuruFocus.com
    Diamond Hill Capital Comments on Boston Scientific Corp Jul 25 2014 
    Diamond Hill Capital Comments on Boston Scientific Corp Jun 26 2014 
    Diamond Hill Select Fund Commentary – First Quarter 2014 Jun 25 2014 
    Diamond Hill Capital Comments on Boston Scientific Corp Jan 15 2014 
    Vanguard Health Care Fund Selling Update Oct 30 2013 
    Diamond Hill Funds Q3 Market Review and Large-Cap Fund Commentary Oct 29 2013 
    Weekly CFO Sells Highlight: BSX, RKUS, MCRL, LRAD and SWKS Sep 08 2013 
    Charles Brandes Top Second Quarter Portfolio Changes Aug 09 2013 
    comment on BSX May 22 2013 
    BSX and ABMD Highlight Increased Insider Buying in the Medical Technology Sector May 14 2013 

    More From Our Partners
    Benzinga's Top Initiations Jul 29 2014 - BENZINGA

    More From Other Websites
    Vascular Solutions Announces Settlement of Patent Lawsuit With Boston Scientific Jul 30 2014
    Boston Scientific wins first trial over transvaginal mesh device Jul 30 2014
    Boston Scientific Wins First Vaginal-Mesh Injury Trial Jul 29 2014
    How Will Boston Scientific (BSX) Stock Respond To This Coverage Initiation? Jul 29 2014
    UPDATE: Sterne Agee Initiates Coverage On Boston Scientific Jul 29 2014
    Dispute Between Medical Giants Johnson & Johnson and Boston Scientific Moving to Trial Jul 27 2014
    AngioDynamics Q4 Earnings Beat, Revenues Up on Higher Sales Jul 24 2014
    Boston Scientific Tops Q2 Earnings, Revenues; Ups EPS View Jul 24 2014
    Boston Scientific profit exceeds expectations as sales rise Jul 24 2014
    Boston Scientific 2Q profit falls 97 percent Jul 24 2014
    Boston Scientific 2Q profit falls 97 percent Jul 24 2014
    Boston Scientific Corp Earnings Call scheduled for 8:00 am ET today Jul 24 2014
    [$$] Boston Scientific Profit Slips Jul 24 2014
    Boston Scientific reports profit as sales rise Jul 24 2014
    BOSTON SCIENTIFIC CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Jul 24 2014
    Q2 2014 Boston Scientific Corporation Earnings Release - Before Market Open Jul 24 2014
    Boston Scientific reports Q2 Rhythm Management revenue growth of 7% Jul 24 2014
    Boston Scientific Announces Results For Second Quarter Ended June 30, 2014 Jul 24 2014
    Boston Scientific Receives CE Mark For Agent™ Drug-Coated Balloon Jul 23 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Email Hide